Cardiac toxicity of  -lytic drugs.
D000433:1-Propanol / Q000494:pharmacology; D000083:Acetanilides / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology; D000526:Alprenolol / Q000494:pharmacology; D000605:Amino Alcohols / Q000494:pharmacology; D000818:Animals; D003408:Cresols / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D006168:Guinea Pigs; D006325:Heart Atria / Q000187:drug effects; D006339:Heart Rate / Q000187:drug effects*; D066298:In Vitro Techniques; D007211:Indoles / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D009578:Nitrobenzenes / Q000494:pharmacology; D010096:Oxprenolol / Q000494:pharmacology; D010208:Papaverine / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology; D011299:Prenylamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D013015:Sotalol / Q000494:pharmacology; D013565:Sympatholytics / Q000494:pharmacology*; D014700:Verapamil / Q000494:pharmacology
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D000605:Amino Alcohols; D003408:Cresols; D004983:Ethanolamines; D007211:Indoles; D009578:Nitrobenzenes; D010627:Phenethylamines; D011437:Propylamines; D013565:Sympatholytics; D010096:Oxprenolol; D000526:Alprenolol; D000433:1-Propanol; D011433:Propranolol; D013015:Sotalol; D014700:Verapamil; D010208:Papaverine; D011299:Prenylamine